SNGX
Soligenix Inc
Halal Rating :
Last Price
$2.31
Last updated:
Market Cap
-
7D Change
-26.2%
1 Year Change
285.0%
Company Overview
Industries
Exchange
Next Earnings Date
Soligenix, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company's pipeline includes treatments for cutaneous T-cell lymphoma, pediatric Crohn's disease, and vaccines for emerging biodefense threats.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| June 30, 2024 | $2342.0 | $1.75m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $117029.0 | $2.23m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Soligenix Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.